无数据
扫 描 看 全 文
Department of Pulmonary and Critical Care Medicine, Zhengzhou Second People’s Hospital, Zhengzhou Affiliated Hospital of Jinan University, Zhengzhou450006, China
Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital of Zhengzhou University, Zhengzhou450052, China
Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital of Zhengzhou University, Zhengzhou450052, China
1.Department of Pulmonary and Critical Care Medicine, Zhengzhou Second People’s Hospital, Zhengzhou Affiliated Hospital of Jinan University, Zhengzhou450006, China
2.Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital of Zhengzhou University, Zhengzhou450052, China
3.Department of Cell Biology, School of Basic and Forensic Medicine, Baotou Medical College, Baotou014040, China
4.Department of Hematology, First Affiliated Hospital of Zhengzhou University, Zhengzhou450052, China
5.Department of Respiratory Medicine, German Center for Lung Research, Hannover Medical School, Hannover30625, Germany
纸质出版日期: 2021-06-15 ,
收稿日期: 2020-09-12 ,
修回日期: 2020-12-21 ,
引用本文
Huiyuan ZHU, Shaochun YAN, Jingshuo WU, 等. 血清巨噬细胞移动抑制因子作为评估过敏性哮喘患者治疗反应的潜在标志物:一项探索性研究[J]. 浙江大学学报(英文版)(B辑:生物医学和生物技术), 2021, 22(6):512-520.
Huiyuan ZHU, Shaochun YAN, Jingshuo WU, et al. Serum macrophage migration inhibitory factor as a potential biomarker to evaluate therapeutic response in patients with allergic asthma: an exploratory study[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2021, 22(6):512-520.
Huiyuan ZHU, Shaochun YAN, Jingshuo WU, 等. 血清巨噬细胞移动抑制因子作为评估过敏性哮喘患者治疗反应的潜在标志物:一项探索性研究[J]. 浙江大学学报(英文版)(B辑:生物医学和生物技术), 2021, 22(6):512-520. DOI: 10.1631/jzus.B2000555.
Huiyuan ZHU, Shaochun YAN, Jingshuo WU, et al. Serum macrophage migration inhibitory factor as a potential biomarker to evaluate therapeutic response in patients with allergic asthma: an exploratory study[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2021, 22(6):512-520. DOI: 10.1631/jzus.B2000555.